a : T 3 and b : T 4 , c and d : T 3 and T 4 at baseline (day 5) and by end of treatment (day 21), Data are shown as means SEM
References 1.Steinmann, B., Royce, P., and Superti-Furga, A
A TUE would be granted if the criteria outlined in the International Standard for Therapeutic Use Exemptions are met
Clinical and preclinical studies suggest that lactate-enriched solutions confer notable benefits in traumatic brain injury and myocardial ischemia, including reductions in cognitive deficits, improvements in cerebral blood flow and attenuation of reperfusion injuries through mechanisms such as anti-inflammatory effects and provision of alternative energy substrates (156,162)
i.p.) also alleviated brain damage severity in rats by ameliorating the excited activity of astrocytes and edema along with proinflammatory cytokines [36]
In research it is studied for sleep-architecture pathway research, hypothalamic-pituitary axis modulation, and stress-response signaling